Application of [18F]FLT‐PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers

Application of [18F]FLT‐PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers

Pulmonary arterial hypertension is a heterogeneous group of diseases characterized by vascular cell proliferation leading to pulmonary vascular remodelling and ultimately right heart failure. Previous data indicated that 3′‐deoxy‐3′‐[18F]‐fluorothymidine (18FLT) positron emission tomography (PET) sc...

Full description

Saved in:
Bibliographic Details
Main Authors: Liza Botros, Samara M.A. Jansen, Ali Ashek, Onno A. Spruijt, Jelco Tramper, Anton Vonk Noordegraaf, Jurjan Aman, Hans Harms, Frances S. deMan, Marc C. Huisman, Lan Zhao, Harm J. Bogaard
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Pulmonary Circulation
Subjects:
pulmonary hypertension
clinical diagnosis
pathogenesis
clinical outcome
Online Access:https://doi.org/10.1177/20458940211028017
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1177/20458940211028017

Similar Items